Max Donley
2014 - Sucampo Pharmaceuticals
In 2014, Max Donley earned a total compensation of $1.1M as EVP, Global Human Resources, Information Technology and Strategy at Sucampo Pharmaceuticals.
Compensation breakdown
| Non-Equity Incentive Plan | $96,177 |
|---|---|
| Option Awards | $828,758 |
| Salary | $187,846 |
| Other | $4,648 |
| Total | $1,117,429 |
Donley received $828.8K in option awards, accounting for 74% of the total pay in 2014.
Donley also received $96.2K in non-equity incentive plan, $187.8K in salary and $4.6K in other compensation.
Rankings
In 2014, Max Donley's compensation ranked 7,085th out of 13,032 executives tracked by ExecPay. In other words, Donley earned more than 45.6% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 7,085 out of 13,032 | 46th |
Division Manufacturing | 2,608 out of 4,965 | 48th |
Major group Chemicals And Allied Products | 887 out of 1,690 | 48th |
Industry group Drugs | 699 out of 1,369 | 49th |
Industry Pharmaceutical Preparations | 536 out of 1,042 | 49th |
Source: SEC filing on April 21, 2017.
Donley's colleagues
We found five more compensation records of executives who worked with Max Donley at Sucampo Pharmaceuticals in 2014.
2014
Peter Greenleaf
Sucampo Pharmaceuticals
Chief Executive Officer
2014
Peter Kiener
Sucampo Pharmaceuticals
Chief Scientific Officer
2014
Matthias Alder
Sucampo Pharmaceuticals
General Counsel
2014
Peter Lichtlen
Sucampo Pharmaceuticals
Chief Medical Officer
2014
Andrew Smith
Sucampo Pharmaceuticals